Trends in pricing and out-of-pocket spending on entecavir among commercially insured patients, 2014-2018 Journal Article uri icon
Overview
abstract

  • This cross-sectional study of health claims from patients with private insurance examines trends in the cost of entecavir prescribed for chronic hepatitis B treatment.

    • Link to Article
    authors
    publication date
  • 2022
    • published in
  • JAMA network open  Journal
    • Research
    keywords
  • Drugs and Drug Therapy
  • Economics
  • Hepatitis
    • Additional Document Info
    volume
  • 5
    • issue
  • 1